Gerard Brady

Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom.

NeuTec Pharma Ltd. develops biopharmaceutical products. It specializes in the development of genetically recombinant antibodies, or “grabs”, for the treatment of life-threatening infections. The firm's products include Mycograb and Aurograb. The company was founded in 1997 and is headquartered in Camberley, the United Kingdom.

Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom.

The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright.

Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom.

Diagnostic Capital provides investment advice.

Source Bioscience Healthcare manufactures and supplies analytical testing laboratory products and provides laboratory services. The private company is based in Nottingham, UK.

Part of Ipca Laboratories Ltd., Onyx Research Chemicals Ltd. is a British company that operates as a parent company. The company is based in Sunderland, UK.

DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom.

Part of Optibiotix Health Plc, Optibiotix Ltd. is a British company that develops biological products for digestive health. The company is based in Heslington, UK. The company was founded in 2012 by Stephen Patrick O'Hara, who has been the CEO since 2012. Optibiotix was acquired by Optibiotix Health Plc on August 05, 2014 for $122.72 million.

The UK Innovation & Science Seed Fund LP, an evergreen fund, invests in seed-stage companies located in the United Kingdom. It targets companies operating in biotechnology, synthetic biology, engineering, agriculture, computer science, and environmental technology sectors. It provides equity financing for seed to early-stage transactions.

MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom.

Continum Group Ltd. engages in the innovative business driven information technology and communications products and solutions. It operates in the followng divisions: Continum 42, Continum, Xempower, and 4 Business Calls. The Continum 42 handles the research and development facilities. The Continum refers to the innovative IT and communication solutions. The Xempower manages hosted applications and IT platforms. The 4 Business Calls manages hosted telephony solutions. The company is headquartered in Bury, the United Kingdom.

The Fertility Partnership Ltd. provides fertility services. Its services include surgical sperm retrieval, time lapse imaging, embryoglue and assisted hatching. The company was founded by David Elan Simckes in 1985 and is headquartered in Oxford, the United Kingdom.

Biobeats Group Ltd. engages in the design and development of mobile software applications. It offers BioBase app. The company was founded by Nadeem Iqbal Kassam, David Plans and Davide Morelli in 2013 and is headquartered in London, the United Kingdom.

Atlantis Healthcare Group Ltd. develops and distributes software related to patient support services. It engages in designing, implementing and operating patient support and adherence programs for the pharmaceutical and other health related industries. The firm’s solutions include self-management behaviors, understanding behavior change, solutions for the patient journey, behavior change techniques and personalized program. The company is headquartered in Auckland, New Zealand.

The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009.

Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom.

Epipole Ltd. manufactures retinal video devices. It offers Automated image analysis, processing, Algorithm development, analytics, medical device design and machine vision. The company was founded by Craig Robertson in 2011 and is headquartered in Inverkeithing, the United Kingdom.

Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013.

Collagen Solutions (UK) Ltd. manufactures medical grade biomedical collagen components for use in regenerative medicines, medical devices, and in-vitro diagnostics. It offers reagents and protocols; and specific collagen formulations for applications, such as sponges, films, and powders. The company is headquartered in London, the United Kingdom.